Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Ihde

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532M C Perry, D C Ihde, J E Herndon, et al.
Cancer|January 15, 1982
Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancerE C Bradley, G P Schechter, M J Matthews, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell linesA F Gazdar, C Kadoyama, D Venzon, et al.
Journal of the National Cancer Institute|December 1, 1980
Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survivalD N Carney, M J Matthews, D C Ihde, et al.
Cancer Treatment Reports|September 1, 1981
Phase I trial of pentamethylmelamine: a clinical and pharmacologic studyD C Ihde, J S Dutcher, R C Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and managementA Surbone, D L Longo, V T DeVita, et al.
Cancer|March 1, 1982
Possible enhancement of vincristine neuropathy by VP-16M Thant, R J Hawley, M T Smith, et al.
Annals of Internal Medicine|November 15, 1990
Tumor cell lines established in vitro: an independent prognostic factor for survival in non-small-cell lung cancerH Stevenson, A F Gazdar, R Phelps, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiationB E Johnson, J Grayson, R W Makuch, et al.
The Journal of Clinical Investigation|June 1, 1987
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and courseB E Johnson, D C Ihde, R W Makuch, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Lung Cancer (Amsterdam, Netherlands)|March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532M C Perry, D C Ihde, J E Herndon, et al.
Cancer|January 15, 1982
Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancerE C Bradley, G P Schechter, M J Matthews, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell linesA F Gazdar, C Kadoyama, D Venzon, et al.
Journal of the National Cancer Institute|December 1, 1980
Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survivalD N Carney, M J Matthews, D C Ihde, et al.
Cancer Treatment Reports|September 1, 1981
Phase I trial of pentamethylmelamine: a clinical and pharmacologic studyD C Ihde, J S Dutcher, R C Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and managementA Surbone, D L Longo, V T DeVita, et al.
Cancer|March 1, 1982
Possible enhancement of vincristine neuropathy by VP-16M Thant, R J Hawley, M T Smith, et al.
Annals of Internal Medicine|November 15, 1990
Tumor cell lines established in vitro: an independent prognostic factor for survival in non-small-cell lung cancerH Stevenson, A F Gazdar, R Phelps, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiationB E Johnson, J Grayson, R W Makuch, et al.
The Journal of Clinical Investigation|June 1, 1987
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and courseB E Johnson, D C Ihde, R W Makuch, et al.
Pageof 13